Literature DB >> 1267870

Severe pseudomembranous colitis after lincomycin and clindamycin.

R F Smart, D A Ramsden, M W Gear, A Nicol, W M Lennox.   

Abstract

Four cases of severe pseudomembranous colitis following the use of lincomycin and clindamycin are described; 2 required emergency total colectomy and 2 died. Cases of such gravity after the use of these drugs have not been previously reported. On hundred and fifty-six orthopaedic cases where clindamycin and lincomycin were used postoperatively are reviewed; 34 had diarrhoea (22 per cent), and 3 of the severe cases occurred in this group. The diagnosis of pseudomembranous colitis may be difficult as the latent period from initiation of drug therapy to commencement of diarrhoea may be as much as 18 days, and that from cessation of drug therapy may be as much as 11 days. The value of early sigmoidoscopy in cases of diarrhoea of obscure aetiology is emphasized, and the characteristic sigmoidoscopic and histological appearances of pseudomembranous colitis are described. As these drugs may produce a lethal condition it is suggested that they should be used with appropriate discretion, especially in the elderly female who appears to be most at risk.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1267870     DOI: 10.1002/bjs.1800630106

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  5 in total

1.  Pseudomembranous colitis.

Authors:  A B Price; D R Davies
Journal:  J Clin Pathol       Date:  1977-01       Impact factor: 3.411

2.  Antimicrobial agent-associated colitis and diarrhea.

Authors:  W L George
Journal:  West J Med       Date:  1980-08

3.  Effect of clindamycin and lincomycin therapy on faecal flora.

Authors:  D A Leigh; K Simmons
Journal:  J Clin Pathol       Date:  1978-05       Impact factor: 3.411

4.  Clostridium difficile infection: a surgical disease in evolution.

Authors:  Joshua L Hermsen; Cosmin Dobrescu; Kenneth A Kudsk
Journal:  J Gastrointest Surg       Date:  2008-07-09       Impact factor: 3.452

5.  Penetration into bone and tissues of clindamycin phosphate.

Authors:  P Baird; S Hughes; M Sullivan; I Willmot
Journal:  Postgrad Med J       Date:  1978-02       Impact factor: 2.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.